Clinical Trial Update: A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Narmafotinib in combination with Modified FOLFIRINOX for metastatic pancreatic cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Modified FOLFIRINOX (modified FOLFIRINOX)
• Narmafotinib (narmafotinib)

Snippet

Sponsor: Amplia Therapeutics Limited | Conditions: Pancreatic Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING